Moss also serves as corporate secretary and chief compliance officer
Los Altos, California, June 27, 2022 /PRNewswire/ — Evommune, Inc., a clinical-stage biotechnology company dedicated to developing innovative medicines for inflammatory diseases, today announced the following appointments: Gregory S. Moss, Esq., as Chief Corporate Strategy and Legal Officer. Mr. Moss will also serve as corporate secretary and chief compliance officer.
Evommune President and CEO Luis Peña said: “Greg’s keen business judgment, leadership experience and personality, and his demonstrated ability to work cross-functionally will be an invaluable asset to our organization and leadership team.”
Most recently, Mr. Moss served as Executive Vice President, General Counsel and Corporate Secretary, and Chief Compliance Officer of Kadmon Holdings, Inc. (now Sanofi Company), where he led legal, compliance and business development operations and contributed to Kadmon’s success. I came to $1.9 billion Mr. Moss led the integration of Kadmon into Sanofi and assisted in broad corporate oversight of legal, compliance, business development, partnership management, human resources, quality assurance and CMC business functions. During his 10-year tenure with Kadmon, Moss held a variety of roles. He has transitioned from a private company to a public company (NYSE and Nasdaq), billion dollars In debt and equity and business development efforts including gene therapy platform spin-offs, various international and domestic collaborations and licenses, co-promotion and distribution agreements, and joint ventures. Moss also helped establish and subsequently led Kadmon’s corporate governance, public company, and healthcare compliance programs. Prior to joining Kadmon in 2012, he was a solicitor in the corporate risk department of a large Australian law firm and an associate with a large Australian law firm and a hedge fund. New York, focused on complex litigation and event-driven outcomes. Moss currently serves on the board of directors of Vitls, Inc and an advisor to Elevate Brands. Mr. Moss holds a Bachelor of Arts and a Bachelor of Laws (BA/LLB) from Macquarie University. Australiaand is a member of the bar new york, usa and New South Wales, Australiaat the entrance before the Supreme Court united states of americasouthern district New YorkNSW Supreme Court, Australia and the High Court Australia.
Moss said: I look forward to joining this incredibly dynamic and experienced team and contributing to the company’s success. ”
About Evommune, Inc.
Evommune is a clinical-stage biotechnology company dedicated to developing innovative medicines for inflammatory diseases. We leverage innovative tissue-based approaches to advance insights and accelerate the development of these innovative therapies. Evommune is led by a proven and experienced leadership team focused on building a strong pipeline of unique therapies to help patients with chronic inflammatory diseases. For more information, visit Evommune.com.
media contact:
Sherrill Sheepy
949-903-4750
[email protected]
Source Evommune, Inc.
